Evidence map›Paper›PMID 30813884›Full record

ArticleMolecular medicine (Cambridge, Mass.)2019

Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes.

Anaïs Begemann, Mario A Acuña, Markus Zweier, Marie Vincent, Katharina Steindl, Ruxandra Bachmann-Gagescu, Annette Hackenberg, Lucia Abela, Barbara Plecko, Judith Kroell-Seger and 7 more

Open access · goldAbstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Degraded sensory coding in a mouse model ofbioRxiv : the preprint server for biology · 2025
    Article
  5. Review
  6. Autism-associatedProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Identification ofJournal of medical genetics · 2025
    Article
  9. Article
  10. Article
  11. DecipheringArXiv · 2024
    Article
  12. Novel KCNQ2 missense variant expands the genotype spectrum of DEE7.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Modelling phenotypes, variants and pathomechanisms of syndromic diseases in different systems.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2024
    Article
  17. Molecular Pharmacology of Selective NaACS chemical neuroscience · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 5 countries.

Anaïs BegemannInstitute of Medical Genetics, University of Zurich, 8952, Schlieren, Zurich, Switzerland.
Mario A Acuñaradiz-Rare Disease Initiative Zürich, Clinical Research Priority Program for Rare Diseases, University of Zurich, 8006, Zurich, Switzerland.
Markus ZweierInstitute of Medical Genetics, University of Zurich, 8952, Schlieren, Zurich, Switzerland.
Marie VincentService de génétique médicale, CHU Nantes, 44093, Nantes, France.
Katharina SteindlInstitute of Medical Genetics, University of Zurich, 8952, Schlieren, Zurich, Switzerland.
Ruxandra Bachmann-GagescuInstitute of Medical Genetics, University of Zurich, 8952, Schlieren, Zurich, Switzerland.
Annette HackenbergDivision of Child Neurology, University Children's Hospital Zurich, 8032, Zurich, Switzerland.
Lucia Abelaradiz-Rare Disease Initiative Zürich, Clinical Research Priority Program for Rare Diseases, University of Zurich, 8006, Zurich, Switzerland.
Barbara Pleckoradiz-Rare Disease Initiative Zürich, Clinical Research Priority Program for Rare Diseases, University of Zurich, 8006, Zurich, Switzerland.
Judith Kroell-SegerChildren's department, Swiss Epilepsy Centre, Clinic Lengg, 8008, Zurich, Switzerland.
Alessandra BaumerInstitute of Medical Genetics, University of Zurich, 8952, Schlieren, Zurich, Switzerland.
Kazuhiro YamakawaLaboratory for Neurogenetics, RIKEN Center for Brain Science, Wako-shi, Saitama, 351-0198, Japan.
Yushi InoueNational Epilepsy Center, NHO Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, 420-8688, Japan.
Reza AsadollahiInstitute of Medical Genetics, University of Zurich, 8952, Schlieren, Zurich, Switzerland.
Heinrich StichtInstitute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054, Erlangen, Germany.
Hanns Ulrich Zeilhoferradiz-Rare Disease Initiative Zürich, Clinical Research Priority Program for Rare Diseases, University of Zurich, 8006, Zurich, Switzerland.
Anita RauchInstitute of Medical Genetics, University of Zurich, 8952, Schlieren, Zurich, Switzerland. anita.rauch@medgen.uzh.ch.
University of Zurich · CHUniversity Children's Hospital Zurich · CHETH Zurich · CHFriedrich-Alexander-Universität Erlangen-Nürnberg · DEGénétique Médicale & Génomique Fonctionelle · FRNational Epilepsy Center · JPRIKEN Center for Brain Science · JPSwiss Epilepsy Center · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDeleterious variants in the voltage-gated sodium channel type 2 (Na

methodsTo further elucidate the genotype-phenotype correlation of SCN2A variants we investigated the functional effects of six variants representing the phenotypic spectrum by whole-cell patch-clamp studies in transfected HEK293T cells and in-silico structural modeling.

resultsThe two variants p.L1342P and p.E1803G detected in patients with early onset epileptic encephalopathy (EE) showed profound and complex changes in channel gating, whereas the BFNIE variant p.L1563V exhibited only a small gain of channel function. The three variants identified in ID patients without seizures, p.R937C, p.L611Vfs*35 and p.W1716*, did not produce measurable currents. Homology modeling of the missense variants predicted structural impairments consistent with the electrophysiological findings.

conclusionsOur findings support the hypothesis that complete loss-of-function variants lead to ID without seizures, small gain-of-function variants cause BFNIE and EE variants exhibit variable but profound Na

Indexed as

AdolescentChildEpilepsy, Benign NeonatalEpileptic SyndromesGenetic Association StudiesHEK293 CellsHumansIntellectual DisabilityNAV1.2 Voltage-Gated Sodium ChannelPhenotypeYoung AdultNAV1.2 Voltage-Gated Sodium ChannelSCN2A protein, humanChannelopathyElectrophysiologyEpilepsyEpileptic encephalopathyIntellectual disabilityNav1.2Patch-clampSCN2AStructural modelling

Identifiers

PMID30813884
PMCPMC6391808
OpenAlexW2922000264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.